This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
Ximenia americana contains several bioactive compounds that contribute to its medicinal effects. Ximenynic acid provides anti-inflammatory and antimicrobial properties, while tannins offer astringent effects that help wound contraction. Prunasin, a cyanogenic glycoside, contributes analgesic effects but requires caution due to potential cyanide release at high doses. Flavonoids and alkaloids provide additional antioxidant and antimicrobial activity. These compounds work synergistically to support traditional uses for wound healing, infections, and pain relief. Evidence Level: C.
Does Ximenia americana interact with any medications?
Limited formal interaction studies exist for Ximenia americana. However, due to its prunasin content, caution is advised when combining with medications metabolized by the liver, as cyanogenic compounds may increase hepatic burden. The herb's potential effects on blood glucose suggest caution with antidiabetic medications. Tannins may reduce absorption of iron supplements and certain medications if taken simultaneously. Patients on prescription medications should consult a healthcare provider before use. Evidence Level: C.
What is the recommended dosage for Ximenia americana?
Traditional adult dosages include a bark decoction of approximately 200ml taken twice daily for internal use. For external applications, a leaf paste can be applied directly to wounds or affected skin areas 2-3 times daily. Due to prunasin content and potential cyanide toxicity at high doses, users should not exceed recommended amounts. Dosage for children under 6 is not established and use is contraindicated. Evidence Level: Traditional.
Is Ximenia americana safe during pregnancy and breastfeeding?
Ximenia americana is considered unsafe during pregnancy and breastfeeding. The plant contains prunasin, a cyanogenic glycoside that can release cyanide, posing significant risks to fetal development and infant health. The potential for uterine stimulation or fetal toxicity exists. Women who are pregnant, planning pregnancy, or breastfeeding should avoid all forms of this herb. Traditional use has not established safety during these periods. Evidence Level: C.
Can Ximenia americana help heal wounds and skin infections?
Traditional medicine systems across Africa, Asia, and the Americas have used Ximenia americana for wound healing and skin infections. The plant's antimicrobial compounds, including ximenynic acid and flavonoids, may help combat infection-causing bacteria, while tannins promote wound contraction through astringent action. Topical application as a leaf paste is the most common traditional approach. Scientific evidence remains limited, warranting further research to confirm efficacy. Evidence Level: C.
What are the side effects of Ximenia americana?
Common side effects include mild nausea, particularly with internal use. The more serious concern is potential cyanide toxicity from prunasin content when consumed in very large doses, which can cause dizziness, headache, weakness, and in severe cases, respiratory depression. Proper dosing minimizes these risks. Users should discontinue use if experiencing adverse symptoms and seek immediate medical attention if signs of cyanide poisoning appear. Evidence Level: C.
PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Ximenia americana, also known as yellow plum or tallow wood, is a wild edible plant with diverse pharmacological properties including anti-inflammatory, antiulcer, and antineoplastic activities [PMID:33746636, 31577938, 37275787, 16005923].
Background
Ximenia americana is a medicinal bushy, spiny shrub or small tree found in regions such as Ethiopia, Mali, and Brazil [PMID:22212502, 33746636, 26304450]. It is utilized as a food source, animal feed, and a source of essential oils and industrial components [PMID:33746636].
Traditional uses
Traditionally used by healers in Africa and Mali to treat infectious and inflammatory ailments [PMID:22212502], skin infections, inflammation of mucous membranes, and for wound healing [PMID:31577938]. It is also used by traditional healers in Burkina Faso for preventing or healing peptic ulcers [PMID:37275787] and in Africa for treating cancer [PMID:24699434].
Active compounds
The plant contains bioactive polyphenols, including flavonoids (such as quercetrin and (-) epi-catechin), procyanidins B and C, and caffeic acid [PMID:22212502, 31174698, 29315228, 31577938]. Other constituents include heteropolysaccharides (composed of glucose, galactose, arabinose, rhamnose, fucose, and galacturonic acid) [PMID:30119202], tannins [PMID:28887918], and C(18) acetylenic fatty acids such as tariric acid [PMID:10820107]. The kernels contain riproximin, a type II ribosome inactivating protein [PMID:24699434].
Mechanism of action
Antinociceptive effects may involve modulation of α2-adrenergic, nitric oxide, glutamatergic, vanilloid, and cyclic guanosine monophosphate pathways [PMID:39770512]. Anti-inflammatory effects in acute pancreatitis are associated with CB2 receptors [PMID:30119202]. Gastroprotective effects are linked to neutrophil inhibition [PMID:29859304] and the participation of sulfhydryl groups (-SH) and nitric oxide (NO) [PMID:29315228]. Antineoplastic activity of aqueous extracts suggests a mechanism of cytotoxicity different from standard agents like gemcitabine or cisplatinum [PMID:16005923].
Clinical evidence
Evidence DPeptic Ulcers
Root bark extracts (10 mg/kg) reduced ulceration index by more than 83% in HCl- and hypothermic stress-induced models [PMID:37275787].
Evidence DGastric Lesions
Aqueous stem bark extract (100-400 mg/kg) inhibited lesions induced by ethanol (76.1%-100%), acidified ethanol (44.9%-94.9%), and indomethacin (52.7%-64.9%) [PMID:29315228].
Evidence DInflammation/Edema
Hydroethanolic bark extract (50-250 mg/kg) showed significant antiedematogenic effects in carrageenan, zymosan, and dextran-induced paw edema [PMID:37597323].
Evidence DPain (Nociception)
Bark extract significantly increased latency in hot plate tests and decreased abdominal contortions and hyperalgesia [PMID:39770512].
Evidence DDepression
Extracts (100-400 mg/kg) decreased immobility time in forced swim and tail suspension tests [PMID:39263345].
Evidence DCancer
Safety & adverse effects
In a clinical evaluation of skin fluorescence, volunteers reported no adverse sensations after extended exposure to Wild Plum formulations [PMID:22882649]. In vitro, stem bark extract showed significant toxicity to fibroblasts only at a high concentration of 1000 μg/mL [PMID:31174698].
Evidence summary
The majority of evidence is derived from in vitro studies and animal models (Level D), demonstrating strong potential for anti-inflammatory, gastroprotective, and antineoplastic effects. There is limited clinical evidence (Level B) regarding its use in cosmetic skin applications.
PubMed sources
1.PMID: 37275787 (2023) — Antiulcer Effect of Aqueous Ethanolic Extracts of Pseudocedrela kotschyi (Schweinf) Harms (Meliaceae) and Ximenia americana L. (Olacaceae). · Journal of experimental pharmacology
2.PMID: 33746636 (2021) — Ximenia americana: Economic Importance, Medicinal Value, and Current Status in Ethiopia. · TheScientificWorldJournal
3.PMID: 35128094 (2022) — Optimization of mucilage extraction from Ximenia americana seed using response surface methodology. · Heliyon
4.PMID: 31577938 (2020) — Phytochemical study, molecular docking, genotoxicity and therapeutic efficacy of the aqueous extract of the stem bark of Ximenia americana L. in the treatment of experimental COPD in rats. · Journal of ethnopharmacology
5.PMID: 37754851 (2023) — Evaluation of How Methacrylate Gelatin Hydrogel Loaded with Ximenia americana L. Extract (Steam Bark) Effects Bone Repair Activity Using Rats as Models.
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
Aqueous extracts showed antiproliferative activity in vitro across 17 tumor cell lines, with high sensitivity in MCF7 breast cancer cells [PMID:16005923].
Evidence BSkin Fluorescence
Application of Wild Plum formulations restored skin fluorescence in volunteers without causing adverse sensations [PMID:22882649].
Evidence DBone Repair
Stem bark extract incorporated into GelMA hydrogel significantly increased new bone formation in rat tibia fractures [PMID:37754851].
Evidence DOral Candidiasis
Extract demonstrated activity against Candida albicans with a MIC of 125 μg/mL [PMID:30960363].
· Journal of functional biomaterials
6.PMID: 39770512 (2024) — Antinociceptive Potential of Ximenia americana L. Bark Extract and Caffeic Acid: Insights into Pain Modulation Pathways. · Pharmaceuticals (Basel, Switzerland)
7.PMID: 22212502 (2012) — Bioactive polyphenols in Ximenia americana and the traditional use among Malian healers. · Journal of ethnopharmacology
8.PMID: 39263345 (2024) — Antidepressant-Like Activity and Molecular Docking Analysis of a Sesquiterpene Lactone Isolated from the Root Bark of Ximenia americana (L.). · Evidence-based complementary and alternative medicine : eCAM
9.PMID: 34141940 (2021) — Bioactive composition, free radical scavenging and fatty acid profile of Ximenia americana grown in Ethiopia. · Heliyon
10.PMID: 37597323 (2023) — Evaluation of the antiedematogenic and anti-inflammatory properties of Ximenia americana L. (Olacaceae) bark extract in experimental models of inflammation. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
12.PMID: 30119202 (2018) — Ximenia americana heteropolysaccharides ameliorate inflammation and visceral hypernociception in murine caerulein-induced acute pancreatitis: Involvement of CB2 receptors. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
13.PMID: 26304450 (2016) — Bioactive compounds and antioxidant potential fruit of Ximenia americana L. · Food chemistry
14.PMID: 11991081 (2002) — Fatty acid compositions of seed oils of Haematostaphis barteri and Ximenia americana. · Bioresource technology
15.PMID: 31174698 (2019) — Ximenia americana L. enhances the antibiotic activity and inhibit the development of kinetoplastid parasites. · Comparative immunology, microbiology and infectious diseases
16.PMID: 29859304 (2018) — The polysaccharide-rich tea of Ximenia americana barks prevents indomethacin-induced gastrointestinal damage via neutrophil inhibition. · Journal of ethnopharmacology
17.PMID: 35761644 (2022) — Phenolic profiling and antioxidant evaluation of extracts from Southern African indigenous fruits byproducts. · Food research international (Ottawa, Ont.)
18.PMID: 28887918 (2017) — Hepatoprotective and hypoglycemic effects of a tannin rich extract from Ximenia americana var. caffra root. · Phytomedicine : international journal of phytotherapy and phytopharmacology
19.PMID: 30960363 (2019) — Tablet of Ximenia Americana L. Developed from Mucoadhesive Polymers for Future Use in Oral Treatment of Fungal Infections. · Polymers
20.PMID: 10820107 (2000) — C(18) acetylenic fatty acids of Ximenia americana with potential pesticidal activity. · Journal of agricultural and food chemistry
21.PMID: 28300877 (2017) — Mast cell concentration and skin wound contraction in rats treated with Ximenia americana L. · Acta cirurgica brasileira
22.PMID: 24699434 (2014) — Riproximin is a recently discovered type II ribosome inactivating protein with potential for treating cancer. · Biotechnology advances
23.PMID: 16005923 (2006) — Identification of potent anticancer activity in Ximenia americana aqueous extracts used by African traditional medicine. · Toxicology and applied pharmacology
24.PMID: 29315228 (2018) — Contribution of Secondary Metabolites to the Gastroprotective Effect of Aqueous Extract of Ximenia americana L. (Olacaceae) Stem Bark in Rats. · Molecules (Basel, Switzerland)
25.PMID: 22882649 (2013) — Wild Plum: novel blue fluorescent compounds capable of luminosity restoration in sun-exposed skin. · Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)
26.PMID: 29680269 (2018) — HPLC profile and antiedematogenic activity of Ximenia americana L. (Olacaceae) in mice models of skin inflammation. · Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association